Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Atricure Inc (ATRC)

Atricure Inc (ATRC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,176,025
  • Shares Outstanding, K 45,626
  • Annual Sales, $ 206,530 K
  • Annual Income, $ -48,160 K
  • 60-Month Beta 1.04
  • Price/Sales 15.02
  • Price/Cash Flow N/A
  • Price/Book 7.38
Trade ATRC with:

Options Overview

Details
  • Implied Volatility 45.02%
  • Historical Volatility 25.69%
  • IV Percentile 11%
  • IV Rank 19.58%
  • IV High 88.08% on 04/21/20
  • IV Low 34.53% on 08/17/20
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 31
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 304
  • Open Int (30-Day) 229

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.38
  • Number of Estimates 2
  • High Estimate -0.36
  • Low Estimate -0.39
  • Prior Year -0.36
  • Growth Rate Est. (year over year) -5.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
58.47 +19.06%
on 03/29/21
69.68 -0.10%
on 04/19/21
+7.15 (+11.45%)
since 03/19/21
3-Month
55.97 +24.36%
on 01/20/21
69.68 -0.10%
on 04/19/21
+13.25 (+23.51%)
since 01/19/21
52-Week
34.04 +104.49%
on 10/30/20
69.68 -0.10%
on 04/19/21
+29.78 (+74.77%)
since 04/17/20

Most Recent Stories

More News
AtriCure Names B. Kristine Johnson Board Chair

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that B. Kristine (Kris) Johnson has been named...

ATRC : 69.61 (+2.37%)
VRAY : 4.17 (-4.79%)
AtriCure to Announce First Quarter 2021 Financial Results

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release its first quarter 2021 financial...

ATRC : 69.61 (+2.37%)
Uptrend Call Working As Atricure Inc Stock Rises 59.8% (ATRC)

SmarTrend identified an Uptrend for Atricure Inc (NASDAQ:ATRC) on November 13th, 2020 at $39.43. In approximately 4 months, Atricure Inc has returned 59.80% as of today's recent price of $63.00.

ATRC : 69.61 (+2.37%)
Atricure Inc Has Returned 69.5% Since SmarTrend Recommendation (ATRC)

SmarTrend identified an Uptrend for Atricure Inc (NASDAQ:ATRC) on November 13th, 2020 at $39.43. In approximately 4 months, Atricure Inc has returned 69.54% as of today's recent price of $66.84.

ATRC : 69.61 (+2.37%)
AtriCure to Participate at the Oppenheimer 31st Annual Healthcare Conference

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating...

ATRC : 69.61 (+2.37%)
AtriCure Reports Fourth Quarter 2020 and Full Year 2020 Financial Results

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced fourth quarter 2020 and full year 2020 financial...

ATRC : 69.61 (+2.37%)
AtriCure, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 23, 2021 / AtriCure, Inc. (NASDAQ:ATRC) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 23, 2021 at 4:30...

ATRC : 69.61 (+2.37%)
Atricure Inc Has Returned 58.4% Since SmarTrend Recommendation (ATRC)

SmarTrend identified an Uptrend for Atricure Inc (NASDAQ:ATRC) on November 13th, 2020 at $39.43. In approximately 3 months, Atricure Inc has returned 58.38% as of today's recent price of $62.44.

ATRC : 69.61 (+2.37%)
$ 156.6 Million Growth in Global Endovenous Ablation Devices Market During 2021-2025 | Featuring Key Vendors Including AngioDynamics Inc., AtriCure Inc., and Eufoton srl | Technavio

, /PRNewswire/ -- Tavio announces the release of its latest report on the endovenous ablation devices market. The market is segmented by product (EVLT devices, RFA devices, and NTNT devices) and geography...

ATRC : 69.61 (+2.37%)
Atricure Inc Shares Up 68.9% Since SmarTrend's Buy Recommendation (ATRC)

SmarTrend identified an Uptrend for Atricure Inc (NASDAQ:ATRC) on November 13th, 2020 at $39.43. In approximately 3 months, Atricure Inc has returned 68.93% as of today's recent price of $66.60.

ATRC : 69.61 (+2.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as...

See More

Key Turning Points

3rd Resistance Point 72.53
2nd Resistance Point 71.10
1st Resistance Point 70.36
Last Price 69.61
1st Support Level 68.19
2nd Support Level 66.76
3rd Support Level 66.02

See More

52-Week High 69.68
Last Price 69.61
Fibonacci 61.8% 56.07
Fibonacci 50% 51.86
Fibonacci 38.2% 47.65
52-Week Low 34.04

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar